Steris PLC Share Price Nyse
Equities
GB00BVVBC028
Medical Equipment, Supplies & Distribution
Sales 2024 * | 5.46B 437B | Sales 2025 * | 5.73B 458B | Capitalization | 20.15B 1,613B |
---|---|---|---|---|---|
Net income 2024 * | 544M 43.55B | Net income 2025 * | 641M 51.31B | EV / Sales 2024 * | 4.23 x |
Net Debt 2024 * | 2.94B 236B | Net Debt 2025 * | 2.41B 193B | EV / Sales 2025 * | 3.94 x |
P/E ratio 2024 * |
37.2
x | P/E ratio 2025 * |
30.2
x | Employees | - |
Yield 2024 * |
1% | Yield 2025 * |
1.09% | Free-Float | 99.73% |
Latest transcript on Steris PLC
Managers | Title | Age | Since |
---|---|---|---|
Daniel Carestio
CEO | Chief Executive Officer | 51 | 31/07/18 |
Michael Tokich
DFI | Director of Finance/CFO | 56 | 31/01/14 |
Julie Winter
IRC | Investor Relations Contact | - | 30/04/04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Breeden
BRD | Director/Board Member | 74 | 31/03/08 |
Director/Board Member | 74 | 30/09/03 | |
Director/Board Member | 58 | 27/07/20 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |